CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation

An Interaction between CD200 and Monoclonal Antibody Agonists to CD200R2 in Development of Dendritic Cells That Preferentially Induce Populations of CD4 + CD25 + T Regulatory Cells

(2014) Reg Gorczynski et al.   JOURNAL OF IMMUNOLOGY

Cannabinoids and Neurodegenerative Diseases

(2012) Julian Romero et al.   CNS & Neurological Disorders-Drug Targets

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells

(2011) Fernando Correa et al.   BRAIN BEHAVIOR AND IMMUNITY

The endocannabinoid system as a target for the treatment of neurodegenerative disease

(2010) Emma L Scotter et al.   BRITISH JOURNAL OF PHARMACOLOGY

The endocannabinoid system as a target for the treatment of neuronal damage

(2010) Javier Fernández-Ruiz et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Anandamide enhances IL-10 production in activated microglia by targeting CB2receptors: Roles of ERK1/2, JNK, and NF-κB

(2009) Fernando Correa et al.   GLIA

Systemic lipopolysaccharide (LPS)-induced microglial activation results in different temporal reduction of CD200 and CD200 receptor gene expression in the brain

(2009) Willias Masocha   JOURNAL OF NEUROIMMUNOLOGY

Distribution of the Immune Inhibitory Molecules CD200 and CD200R in the Normal Central Nervous System and Multiple Sclerosis Lesions Suggests Neuron-Glia and Glia-Glia Interactions

(2009) Nathalie Koning et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis

(2009) F. Loría et al.   NEUROBIOLOGY OF DISEASE

CD200-FC, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis

(2008) Egle Šimelyte et al.   ARTHRITIS AND RHEUMATISM

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

(2008) Frida Loría et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation

(2008) Douglas G. Walker et al.   EXPERIMENTAL NEUROLOGY

Therapeutic potential of CB2 targeting in multiple sclerosis

(2008) Fabian Docagne et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

CNS inflammation and neuronal degeneration is aggravated by impaired CD200–CD200R-mediated macrophage silencing

(2008) Sven G. Meuth et al.   JOURNAL OF NEUROIMMUNOLOGY

The endocannabinoid system is modulated in response to spinal cord injury in rats

(2008) Daniel Garcia-Ovejero et al.   NEUROBIOLOGY OF DISEASE

Endocannabinoid signaling in microglial cells

(2008) Nephi Stella   NEUROPHARMACOLOGY

CB2cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies

(2007) Arévalo-Martín et al.   BRITISH JOURNAL OF PHARMACOLOGY

CB2receptors in the brain: role in central immune function

(2007) G A Cabral et al.   BRITISH JOURNAL OF PHARMACOLOGY